Literature DB >> 8253743

Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide.

A Bielawska1, H M Crane, D Liotta, L M Obeid, Y A Hannun.   

Abstract

Ceramide is emerging as a putative second messenger mediating effects of extracellular agents on cell growth and differentiation (Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. (1990) J. Biol. Chem. 265, 15822-15831) and programed cell death (Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. (1993) Science 259, 1769-1771). In this study, the eight stereoisomers of C2-ceramide and dihydroceramide were synthesized, and their cellular activity was investigated. The four stereoisomers of C2-ceramide were active in inhibition of cell growth and induction of apoptosis with modest differences in potency. On the other hand, with C2-dihydroceramide only the threo compounds were active in these assays whereas the erythro compounds were totally inactive. Thus, of the two naturally occurring molecules, the analog of D-erythro-ceramide (with the 4-5 trans double bond) was active, whereas the analog of D-erythro-dihydroceramide was inactive. These results demonstrate the specificity of ceramide action and suggest that the introduction of the double bond is critical for imparting the biochemical and biological activity of ceramide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253743

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Synthesis and bioevaluation of omega-N-amino analogs of B13.

Authors:  Aiping Bai; Zdzislaw M Szulc; Jacek Bielawski; Nalini Mayroo; Xiang Liu; James Norris; Yusuf A Hannun; Alicja Bielawska
Journal:  Bioorg Med Chem       Date:  2009-01-31       Impact factor: 3.641

3.  Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis.

Authors:  Justin M Snider; Magali Trayssac; Christopher J Clarke; Nicholas Schwartz; Ashley J Snider; Lina M Obeid; Chiara Luberto; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-12-20       Impact factor: 5.922

4.  Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity.

Authors:  C G Tepper; S Jayadev; B Liu; A Bielawska; R Wolff; S Yonehara; Y A Hannun; M F Seldin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

5.  prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2.

Authors:  M J Smyth; D K Perry; J Zhang; G G Poirier; Y A Hannun; L M Obeid
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

6.  p53-dependent ceramide response to genotoxic stress.

Authors:  G S Dbaibo; M Y Pushkareva; R A Rachid; N Alter; M J Smyth; L M Obeid; Y A Hannun
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

7.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

Authors:  G S Dbaibo; M Y Pushkareva; S Jayadev; J K Schwarz; J M Horowitz; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes.

Authors:  Frank J Raucci; Dayanjan S Wijesinghe; Charles E Chalfant; Clive M Baumgarten
Journal:  Cardiovasc Res       Date:  2009-12-14       Impact factor: 10.787

9.  Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.

Authors:  Kristin Gustafsson; Birgitta Sander; Jacek Bielawski; Yusuf A Hannun; Jenny Flygare
Journal:  Mol Cancer Res       Date:  2009-07       Impact factor: 5.852

10.  Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells.

Authors:  N Mizushima; H Kohsaka; N Miyasaka
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.